CTIX remains in Bull Pennant/coil at Key Resistance

Strong close. Parabolic rally remains intact.

It would appear my hunch that the PR of start of the second cohort was indeed priced in.

Remaining on protocol approving doubling of dose would have been a bit extra good, but it appears it was expected.

I'll do a chart as time allows.